Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$152.59 – $203.78
100% from low
Exchange
NASDAQ
ETF
Borrow rate
0.31%
Easy to borrow
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BBHVanEck Biotech ETF | $203.74 | +1.32% | $372M | — |
| BLUXBluemonte Dynamic Total Market ETF | $31.80 | +0.22% | $435M | — |
| DAUGFT Vest U.S. Equity Deep Buffer ETF - August | $46.75 | +0.79% | $365M | — |
| DDECFT Vest U.S. Equity Deep Buffer ETF - December | $47.23 | +0.61% | $358M | — |
| DJANFT Vest U.S. Equity Deep Buffer ETF - January |
No company description on file.
No one on the platform currently holds BBH.
No tracked institution reports a position in BBH as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-22 | $0.9565 | 2025-12-26 |
| 2024-12-23 | $1.2517 | 2024-12-24 |
| 2023-12-18 | $0.7127 | 2023-12-22 |
| Execution date | Ratio |
|---|---|
| 2012-02-14 | 3-for-1 |
No one on the platform has traded BBH yet.
| $45.41 |
| +1.18% |
| $365M |
| — |
| DJDInvesco Dow Jones Industrial Average Dividend ETF | $63.74 | +0.38% | $453M | — |
| FADFirst Trust Multi Cap Growth AlphaDEX Fund | $197.28 | +1.65% | $540M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$RVMD $XBI $BBH $SPY $LABU Charles Zhu Reiterates Buy on RVMD, Maintains $263 Price Target on Strong Darax. Data and Regulatory Progress Revolution Medicines Is Maintained at Outperform by Oppenheimer $RVMD Wedbush reiterates Outperform on Revolution Medicines after ASCO data Revolution Medicines price target raised to $195 from $169 at H.C. Wainwright Wells Fargo Sticks to Its Buy Rating for Revolution Medicines (RVMD) Ami Fadia Reiterates Buy on Strong Daraxonrasib Data, Maintains $183 Price Target
View on StockTwits ↗$RVMD $SPY $IBB $XBI $BBH $RVMD - Revolutionary https://finance.yahoo.com/sectors/healthcare/articles/revolution-medicines-pancreatic-cancer-pill-024312342.html
View on StockTwits ↗GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment $GILD $BBH $IBB https://stocktwits.com/news/equity/markets/gild-stock-jumps-after-winning-accelerated-fda-approval-for-hdv-treatment/cZgRlDmReYE
View on StockTwits ↗$LEXX Biotech is a clear 2026 & 2027 winner 🔥 Right place, right time, rising tide 📈 $XBI $IBB $BBH
View on StockTwits ↗$ABVX can drop as quick as it jumped. $XBI $IBB $BBH $FBT
View on StockTwits ↗$BBH Share Price: $184.90 Contract Selected: Sep 18, 2026 $185 Calls Buy Zone: $10.20 – $12.60 Target Zone: $19.11 – $23.35 Potential Upside: 77% ROI Time to Expiration: 175 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$BBH Current Stock Price: $197.25 Contracts to trade: $195.0 BBH Mar 20 2026 Call Entry: $4.50 Exit: $6.41 ROI: 43% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$BBH Share Price: $197.25 Contract Selected: Sep 18, 2026 $210 Calls Buy Zone: $5.95 – $7.35 Target Zone: $11.24 – $13.74 Potential Upside: 78% ROI Time to Expiration: 207 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? $PLRZ $BBH $IBB https://stocktwits.com/news/equity/markets/why-did-plrz-stock-gain-premarket/cZbU3zNR4Yr
View on StockTwits ↗$BBH Current Stock Price: $198.18 Contracts to trade: $195.0 BBH Feb 20 2026 Call Entry: $3.00 Exit: $5.67 ROI: 89% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock $REGN $BBH $IBB $THNR https://stocktwits.com/news/equity/markets/regn-stock-slips-regeneron-earnings-q4-eylea-hd-revenue/cmySjWfR4S5
View on StockTwits ↗$BBH Share Price: $197.52 Contract Selected: Jun 18, 2026 $200 Calls Buy Zone: $7.22 – $8.93 Target Zone: $12.67 – $15.49 Potential Upside: 66% ROI Time to Expiration: 144 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗83% of Biotech stocks in $BBH have outperformed the S&P 500 $SPY over the past quarter, yet it remains when of the most disliked groups. In fact, sentiment remains near Liberation Day lows. You'll have to wait until February to get a look at their fourth quarter earnings, but that's a lot of time to drift. https://www.earningswhispers.com/wrs $REGN $VRTX $AMGN
View on StockTwits ↗$BBH Valuation sensitivity is high because visibility is uneven; pipeline visibility needs clearer corroboration — improving transparency could compress perceived risk. Until validation appears, volatility remains the default.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.